Bio-Rad Laboratories (BIO) Revenue & Revenue Breakdown
Bio-Rad Laboratories Revenue Highlights
Latest Revenue (Y)
$2.67T
Latest Revenue (Q)
$638.48M
Main Segment (Y)
Clinical Diagnostics
Main Geography (Y)
UNITED STATES
Bio-Rad Laboratories Revenue by Period
Bio-Rad Laboratories Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.67T | 95225.65% |
| 2022-12-31 | $2.80B | -4.12% |
| 2021-12-31 | $2.92B | 14.81% |
| 2020-12-31 | $2.55B | 10.12% |
| 2019-12-31 | $2.31B | 0.94% |
| 2018-12-31 | $2.29B | 6.02% |
| 2017-12-31 | $2.16B | 4.45% |
| 2016-12-31 | $2.07B | 2.41% |
| 2015-12-31 | $2.02B | -7.15% |
| 2014-12-31 | $2.18B | 1.99% |
| 2013-12-31 | $2.13B | 3.07% |
| 2012-12-31 | $2.07B | -0.21% |
| 2011-12-31 | $2.07B | 7.60% |
| 2010-12-31 | $1.93B | 8.01% |
| 2009-12-31 | $1.78B | 1.13% |
| 2008-12-31 | $1.76B | 20.76% |
| 2007-12-31 | $1.46B | 14.69% |
| 2006-12-31 | $1.27B | 7.87% |
| 2005-12-31 | $1.18B | 8.35% |
| 2004-12-31 | $1.09B | 8.63% |
| 2003-12-31 | $1.00B | 12.40% |
| 2002-12-31 | $892.72M | 9.20% |
| 2001-12-31 | $817.51M | 12.62% |
| 2000-12-31 | $725.88M | 32.10% |
| 1999-12-31 | $549.50M | 24.35% |
| 1998-12-31 | $441.90M | 3.51% |
| 1997-12-31 | $426.90M | 1.93% |
| 1996-12-31 | $418.80M | 5.60% |
| 1995-12-31 | $396.60M | 11.62% |
| 1994-12-31 | $355.30M | 8.13% |
| 1993-12-31 | $328.60M | - |
Bio-Rad Laboratories generated $2.67T in revenue during NA 2023, up 95225.65% compared to the previous quarter, and up 116643.44% compared to the same period a year ago.
Bio-Rad Laboratories Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $638.48M | 4.53% |
| 2024-03-31 | $610.82M | -10.33% |
| 2023-12-31 | $681.18M | 7.76% |
| 2023-09-30 | $632.12M | -7.19% |
| 2023-06-30 | $681.11M | 0.63% |
| 2023-03-31 | $676.84M | -7.32% |
| 2022-12-31 | $730.29M | 7.27% |
| 2022-09-30 | $680.80M | -1.49% |
| 2022-06-30 | $691.10M | -1.28% |
| 2022-03-31 | $700.06M | -4.46% |
| 2021-12-31 | $732.77M | -1.91% |
| 2021-09-30 | $747.05M | 4.35% |
| 2021-06-30 | $715.93M | -1.49% |
| 2021-03-31 | $726.80M | -7.98% |
| 2020-12-31 | $789.84M | 22.03% |
| 2020-09-30 | $647.26M | 20.56% |
| 2020-06-30 | $536.88M | -6.08% |
| 2020-03-31 | $571.64M | -8.45% |
| 2019-12-31 | $624.43M | 11.38% |
| 2019-09-30 | $560.63M | -2.09% |
| 2019-06-30 | $572.62M | 3.36% |
| 2019-03-31 | $553.98M | -10.29% |
| 2018-12-31 | $617.54M | 13.28% |
| 2018-09-30 | $545.14M | -5.34% |
| 2018-06-30 | $575.91M | 4.42% |
| 2018-03-31 | $551.52M | -11.11% |
| 2017-12-31 | $620.43M | 15.97% |
| 2017-09-30 | $535.00M | 6.01% |
| 2017-06-30 | $504.67M | 0.92% |
| 2017-03-31 | $500.05M | -12.49% |
| 2016-12-31 | $571.45M | 12.33% |
| 2016-09-30 | $508.75M | -1.55% |
| 2016-06-30 | $516.78M | 9.67% |
| 2016-03-31 | $471.20M | -17.41% |
| 2015-12-31 | $570.56M | 21.41% |
| 2015-09-30 | $469.96M | -7.14% |
| 2015-06-30 | $506.10M | 7.04% |
| 2015-03-31 | $472.82M | -20.96% |
| 2014-12-31 | $598.22M | 12.74% |
| 2014-09-30 | $530.64M | -1.15% |
| 2014-06-30 | $536.83M | 5.40% |
| 2014-03-31 | $509.34M | -15.48% |
| 2013-12-31 | $602.63M | 19.32% |
| 2013-09-30 | $505.07M | -3.86% |
| 2013-06-30 | $525.32M | 5.13% |
| 2013-03-31 | $499.67M | -12.92% |
| 2012-12-31 | $573.84M | 15.07% |
| 2012-09-30 | $498.70M | -2.30% |
| 2012-06-30 | $510.42M | 4.97% |
| 2012-03-31 | $486.28M | -11.62% |
| 2011-12-31 | $550.24M | 6.53% |
| 2011-09-30 | $516.51M | -0.99% |
| 2011-06-30 | $521.66M | 7.53% |
| 2011-03-31 | $485.12M | -9.11% |
| 2010-12-31 | $533.72M | 13.20% |
| 2010-09-30 | $471.50M | 0.82% |
| 2010-06-30 | $467.66M | 2.96% |
| 2010-03-31 | $454.23M | -8.25% |
| 2009-12-31 | $495.07M | 7.38% |
| 2009-09-30 | $461.06M | 7.93% |
| 2009-06-30 | $427.18M | 6.55% |
| 2009-03-31 | $400.93M | -10.50% |
| 2008-12-31 | $447.96M | 1.39% |
| 2008-09-30 | $441.84M | -2.33% |
| 2008-06-30 | $452.36M | 7.14% |
| 2008-03-31 | $422.20M | -8.16% |
| 2007-12-31 | $459.69M | - |
Bio-Rad Laboratories generated $638.48M in revenue during Q2 2024, up 4.53% compared to the previous quarter, and up 94.33% compared to the same period a year ago.
Bio-Rad Laboratories Revenue Breakdown
Bio-Rad Laboratories Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Clinical Diagnostics | $1.49B | $1.45B | $1.52B | $1.31B | $1.41B |
| Other Segments | $3.60M | $4.00M | $5.80M | $8.60M | $13.80M |
| Life Science | $1.18B | $1.35B | $1.40B | $1.23B | $885.90M |
Bio-Rad Laboratories's latest annual revenue breakdown by segment (product or service), as of Dec 23: Clinical Diagnostics (55.75%), Life Science (44.11%), and Other Segments (0.13%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Segments | $500.00K | $1.20M | $500.00K | $800.00K | $1.10M | $900.00K | $1.00M | $900.00K | $1.10M | $1.20M | $1.30M | $1.50M | $1.80M | $1.60M | $1.10M | $1.60M | $4.10M | $3.40M | $3.10M | $3.10M |
| Clinical Diagnostics | $368.60M | $389.00M | $368.10M | $380.10M | $352.10M | $369.60M | $361.90M | $367.80M | $351.80M | $404.90M | $372.20M | $380.20M | $358.50M | $359.60M | $322.20M | $283.20M | $340.30M | $379.10M | $341.80M | $357.10M |
| Life Science | $241.70M | $291.10M | $263.50M | $300.20M | $323.60M | $359.70M | $317.90M | $322.40M | $347.20M | $326.60M | $373.50M | $334.20M | $366.50M | $428.60M | $324.00M | $252.10M | $227.20M | $242.00M | $215.70M | $212.40M |
Bio-Rad Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Clinical Diagnostics (60.35%), Life Science (39.57%), and Other Segments (0.08%).
Bio-Rad Laboratories Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| UNITED STATES | $1.12B | $1.16B | $1.13B | $1.00B | $899.10M |
| Americas | $166.60M | $155.40M | $156.60M | $136.60M | $137.30M |
| Asia Pacific | $563.00M | $639.40M | $688.40M | $546.50M | $505.00M |
| Europe | $819.80M | $851.90M | $946.90M | $857.70M | $770.30M |
Bio-Rad Laboratories's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (42.00%), Europe (30.69%), Asia Pacific (21.08%), and Americas (6.24%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $252.90M | $261.80M | $275.40M | $287.70M | $297.00M | $307.30M | $284.10M | $281.60M | $282.50M | $269.20M | $315.40M | $274.60M | $271.40M | $319.40M | $250.40M | $205.40M | $229.50M | $225.10M | $225.80M | $222.10M |
| Asia Pacific | $117.20M | $165.30M | $118.90M | $143.00M | $135.80M | $169.10M | $156.80M | $152.70M | $160.90M | $176.20M | $171.20M | $172.10M | $168.90M | $164.20M | $142.00M | $129.00M | $111.40M | $150.70M | $120.70M | $127.30M |
| Americas | $40.50M | $43.50M | $44.70M | $39.20M | $39.20M | $38.20M | $39.80M | $39.50M | $37.80M | $38.60M | $38.90M | $40.10M | $38.80M | $39.10M | $34.00M | $28.50M | $35.00M | $34.50M | $32.20M | $35.00M |
| Europe | $200.20M | $210.70M | $193.10M | $211.20M | $204.80M | $215.60M | $200.10M | $217.30M | $218.90M | $248.70M | $221.50M | $229.10M | $247.70M | $267.10M | $220.90M | $174.00M | $195.70M | $214.20M | $181.90M | $188.20M |
Bio-Rad Laboratories's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (41.40%), Europe (32.78%), Asia Pacific (19.19%), and Americas (6.63%).
Bio-Rad Laboratories Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BIO | Bio-Rad Laboratories | $2.67T | $638.48M |
| STE | STERIS | $5.14B | $1.28B |
| DXCM | DexCom | $3.62B | $1.00B |
| BRKR | Bruker | $2.96B | $800.70M |
| ZBH | Zimmer Biomet | $1.94B | $1.89B |
| PODD | Insulet | $1.70B | $488.50M |
| ITGR | Integer | $1.60B | $753.01M |
| GMED | Globus Medical | $1.57B | $629.69M |
| CNMD | CONMED | $1.24B | $332.10M |
| PEN | Penumbra | $1.06B | $299.40M |
| TNDM | Tandem Diabetes Care | $747.72M | $331.03M |
| SWAV | ShockWave Medical | $730.23M | $218.81M |
| INSP | Inspire Medical Systems | $624.80M | $195.88M |
| NVCR | NovoCure | $509.34M | $150.36M |
| NARI | Inari Medical | $493.63M | $145.82M |
| GKOS | Glaukos | $314.71M | $95.69M |
| ANIK | Anika Therapeutics | $166.66M | $41.92M |
BIO Revenue FAQ
What is Bio-Rad Laboratories’s yearly revenue?
Bio-Rad Laboratories's yearly revenue for 2023 was $2.67T, representing an increase of 95225.65% compared to 2022. The company's yearly revenue for 2022 was $2.8B, representing a decrease of -4.12% compared to 2021. BIO's yearly revenue for 2021 was $2.92B, representing an increase of 14.81% compared to 2020.
What is Bio-Rad Laboratories’s quarterly revenue?
Bio-Rad Laboratories's quarterly revenue for Q2 2024 was $638.48M, a 4.53% increase from the previous quarter (Q1 2024), and a -6.26% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $610.82M, a -10.33% decrease from the previous quarter (Q4 2023), and a -9.75% decrease year-over-year (Q1 2023). BIO's quarterly revenue for Q4 2023 was $681.18M, a 7.76% increase from the previous quarter (Q3 2023), and a -6.72% decrease year-over-year (Q4 2022).
What is Bio-Rad Laboratories’s revenue growth rate?
Bio-Rad Laboratories's revenue growth rate for the last 3 years (2021-2023) was 91301.91%, and for the last 5 years (2019-2023) was 115456.06%.
What are Bio-Rad Laboratories’s revenue streams?
Bio-Rad Laboratories's revenue streams in c 23 are Clinical Diagnostics, Other Segments, and Life Science. Clinical Diagnostics generated $1.49B in revenue, accounting 55.75% of the company's total revenue, up 2.64% year-over-year. Other Segments generated $3.6M in revenue, accounting 0.13% of the company's total revenue, down -10.00% year-over-year. Life Science generated $1.18B in revenue, accounting 44.11% of the company's total revenue, down -12.53% year-over-year.
What is Bio-Rad Laboratories’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Bio-Rad Laboratories was Clinical Diagnostics. This segment made a revenue of $1.49B, representing 55.75% of the company's total revenue.